US Tech 100

18,203.60

-0.16%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
UK
LSE
Medivir Ab (0GP7)
Medivir Ab (0GP7) News

0GP7

Medivir Ab (0GP7)

Medivir Ab

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0GP7

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
01/15/2024	1:45AM	PR Newswire (US)	Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox	LSE:0GP7	Medivir Ab
01/04/2024	1:47AM	PR Newswire (US)	Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study	LSE:0GP7	Medivir Ab
12/19/2023	1:54AM	PR Newswire (US)	Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan	LSE:0GP7	Medivir Ab
12/13/2023	4:12AM	PR Newswire (US)	Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval	LSE:0GP7	Medivir Ab
12/06/2023	5:20AM	PR Newswire (US)	Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway	LSE:0GP7	Medivir Ab
12/06/2023	1:44AM	PR Newswire (US)	Medivir to present at the Carlsquare Equity Research Investor Day	LSE:0GP7	Medivir Ab
12/01/2023	4:32AM	PR Newswire (US)	Bulletin from Extraordinary General Meeting in Medivir AB (publ)	LSE:0GP7	Medivir Ab
11/27/2023	2:52AM	PR Newswire (US)	Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC	LSE:0GP7	Medivir Ab
11/22/2023	1:46AM	PR Newswire (US)	Medivir to present at the Redeye Life Science Day	LSE:0GP7	Medivir Ab
11/21/2023	1:48AM	PR Newswire (US)	Medivir to present at the Erik Penser Bank Company Event	LSE:0GP7	Medivir Ab
11/13/2023	2:49AM	PR Newswire (US)	Medivir to present clinical data at ASCO-GI with fostrox + Lenvima in HCC and shares positive response from Type D meeting with FDA	LSE:0GP7	Medivir Ab
11/07/2023	2:50PM	PR Newswire (US)	Notice of Extraordinary General Meeting in Medivir AB (publ)	LSE:0GP7	Medivir Ab
10/27/2023	2:01AM	PR Newswire (US)	MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2023	LSE:0GP7	Medivir Ab
10/25/2023	1:46AM	PR Newswire (US)	Medivir to report new and updated data from ongoing phase 2a HCC study as part of its Q3 report on Friday	LSE:0GP7	Medivir Ab
10/23/2023	1:48AM	PR Newswire (US)	Nomination Committee of Medivir appointed	LSE:0GP7	Medivir Ab
10/20/2023	8:29AM	PR Newswire (US)	Change in Medivir's Board of Directors	LSE:0GP7	Medivir Ab
05/16/2023	11:38AM	PR Newswire (US)	Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2023	LSE:0GP7	Medivir Ab
05/04/2023	9:55AM	PR Newswire (US)	Execution of the annual general meeting's resolution on the removal of share class in Medivir AB (publ)	LSE:0GP7	Medivir Ab
05/04/2023	9:25AM	PR Newswire (US)	Resolutions at the Annual General Meeting in Medivir on 4 May 2023	LSE:0GP7	Medivir Ab
04/27/2023	2:06AM	PR Newswire (US)	MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2023	LSE:0GP7	Medivir Ab
04/17/2023	2:30AM	PR Newswire (US)	Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination	LSE:0GP7	Medivir Ab
04/04/2023	4:03AM	PR Newswire (US)	Medivir 2022 Annual Report published	LSE:0GP7	Medivir Ab
03/31/2023	5:25AM	PR Newswire (US)	Notice of Annual General Meeting of Medivir AB (publ)	LSE:0GP7	Medivir Ab
03/17/2023	3:01AM	PR Newswire (US)	Medivir to present data on additive efficacy of fostrox in triple combination with anti-PD1 and kinase inhibitor in nonclinical tumor models at AACR	LSE:0GP7	Medivir Ab
03/14/2023	3:18AM	PR Newswire (US)	First patient dosed in the phase 2a part of Medivir's study with fostrox in combination with Lenvima®	LSE:0GP7	Medivir Ab
03/08/2023	9:08AM	PR Newswire (US)	Medivir to present at the Stockholm Corporate Finance Life Science Day	LSE:0GP7	Medivir Ab
02/23/2023	2:03AM	PR Newswire (US)	Medivir to present at the Erik Penser Bank Healthcare Day	LSE:0GP7	Medivir Ab
02/21/2023	2:54AM	PR Newswire (US)	Pia Baumann takes up her position as Chief Medical Officer	LSE:0GP7	Medivir Ab
02/20/2023	4:04AM	PR Newswire (US)	Medivir has determined the recommended phase 2 dose for fostrox in combination with Lenvima in HCC	LSE:0GP7	Medivir Ab
02/15/2023	2:15AM	PR Newswire (US)	MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2022	LSE:0GP7	Medivir Ab